Legal and Scientific Considerations in Nonclinical Assessment of Biotechnology Products

• 1 October 2003
• journal article
• research article
• Published by Springer Nature in Drug Information Journal
• Vol. 37  (4) , 397-406
• https://doi.org/10.1177/009286150303700406

Abstract

Keywords

• NONCLINICAL
• LIABILITY
• BIOTECHNOLOGY DERIVED PRODUCTS
• EFFICACY
• SAFETY
• SCIENTIFIC